BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 18536005)

  • 1. Investigating DRG cost weights for hospitals in middle income countries.
    Ghaffari S; Doran C; Wilson A; Aisbett C; Jackson T
    Int J Health Plann Manage; 2009; 24(3):251-64. PubMed ID: 18536005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The practical application of DRG and casemix information in planning and funding models.
    Henderson N
    Aust Health Rev; 1991; 14(3):277-84. PubMed ID: 10117336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical redesign using all patient refined diagnosis related groups.
    Sedman AB; Bahl V; Bunting E; Bandy K; Jones S; Nasr SZ; Schulz K; Campbell DA
    Pediatrics; 2004 Oct; 114(4):965-9. PubMed ID: 15466092
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Describing Iranian hospital activity using Australian Refined DRGs: a case study of the Iranian Social Security Organisation.
    Ghaffari S; Jackson TJ; Doran CM; Wilson A; Aisbett C
    Health Policy; 2008 Jul; 87(1):63-71. PubMed ID: 17980930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management accounting in hospital setting].
    Brzović Z; Richter D; Simunić S; Bozić R; Hadjina N; Piacun D; Harcet B
    Lijec Vjesn; 1998 Dec; 120(12):363-5. PubMed ID: 19658356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimates of costs by DRG in Sydney teaching hospitals: an application of the Yale cost model.
    Palmer G; Aisbett C; Fetter R; Winchester L; Reid B; Rigby E
    Aust Health Rev; 1991; 14(3):314-34. PubMed ID: 10117339
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of lengths of stay and DRG cost weights in dermatology from 2003 to 2006.
    Wenke A; Müller ML; Babapirali J; Rompel R; Hensen P
    J Dtsch Dermatol Ges; 2009 Aug; 7(8):680-7. PubMed ID: 19250249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Yale Cost Model and cost centres: servant or master?
    Rigby E
    Aust Health Rev; 1993; 16(1):89-102. PubMed ID: 10127677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DRG production costs: one more dimension in management information for South Australia hospitals.
    Hindle D; Scutery J
    Aust Health Rev; 1988; 11(4):320-32. PubMed ID: 10313069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of nationwide pharmacy charges per DRG.
    Curtiss FR
    Am J Hosp Pharm; 1985 Oct; 42(10):2168-74. PubMed ID: 3933336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hospital accounting and information systems: a critical assessment.
    Macintosh NB
    Aust Health Rev; 1991; 14(1):46-56. PubMed ID: 10116914
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medicare program; changes to the hospital inpatient prospective payment systems and fiscal year 2007 rates; fiscal year 2007 occupational mix adjustment to wage index; health care infrastructure improvement program; selection criteria of loan program for qualifying hospitals engaged in cancer-related health care and forgiveness of indebtedness; and exclusion of vendor purchases made under the competitive acquisition program (CAP) for outpatient drugs and biologicals under part B for the purpose of calculating the average sales price (ASP). Final rules and interim final rule with comment period.
    Centers for Medicare and Medicaid Services (CMS), HHS
    Fed Regist; 2006 Aug; 71(160):47869-8351. PubMed ID: 16921666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective casemix-based funding, analysis and financial impact of cost outliers in all-patient refined diagnosis related groups in three Belgian general hospitals.
    Pirson M; Martins D; Jackson T; Dramaix M; Leclercq P
    Eur J Health Econ; 2006 Mar; 7(1):55-65. PubMed ID: 16416135
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of misclassification errors on case mix measurement.
    Sutherland JM; Botz CK
    Health Policy; 2006 Dec; 79(2-3):195-202. PubMed ID: 16439035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Evaluation of flat-rate payment in radiation oncology. German experience with disease-related groups for inpatient funding in radiation oncology].
    Glocker S; Loskamp N; Bamberg M; Roeder N
    Strahlenther Onkol; 2006 Jun; 182(6):305-11. PubMed ID: 16703284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of MY-DRG casemix pharmacy service weights in UKM Medical Centre in Malaysia.
    Ali Jadoo SA; Aljunid SM; Nur AM; Ahmed Z; Van Dort D
    Daru; 2015 Feb; 23(1):14. PubMed ID: 25889668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ratio of costs to charges: how good a basis for estimating costs?
    Shwartz M; Young DW; Siegrist R
    Inquiry; 1995-1996 Winter; 32(4):476-81. PubMed ID: 8567084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital costs, resource characteristics, and the dynamics of death for hospitalized patients in cardiology Diagnosis-Related Groups.
    Muñoz E; Chalfin D; Birnbaum E; Mulloy K; Cohen J; Wise L
    Heart Lung; 1989 Mar; 18(2):164-71. PubMed ID: 2494133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Casemix and costing hospital information program, Brisbane South Regional Health Authority: a preliminary study to determine the emergency department component of DRG costs.
    Lloyd S; Kateley D; Bromwich C; Scott B
    Aust Health Rev; 1992; 15(3):299-318. PubMed ID: 10121781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective payment to encourage system wide quality improvement.
    McNair P; Borovnicar D; Jackson T; Gillett S
    Med Care; 2009 Mar; 47(3):272-8. PubMed ID: 19194336
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.